Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Bayer
 More »

  • Bayer Collaboration Could Net $540M+ for Compugen
    Bayer HealthCare will team up with Compugen on preclinical research toward antibody-based ... targets discovered by Compugen, with Bayer exercising full control over further ...
    8-5-2013
  • Drug Candidates on Trial
    ... The current trial is to be a randomized, double-blind study designed to assess the safety of ORMD-0801. Hemophilia A > Bayer HealthCare started to enroll patients in an ...
    7-22-2013
  • Top 15 Pharma Companies of 2013
    five were ranked for the first time (Bayer, Eli Lilly, Takeda, Astellas, and Daiichi ... 18.7% Position on 2012 List: #9 #8. Bayer 2013 Market Cap: $87.527 billion (3/31: ...
    7-19-2013
  • Evotec Scores $1.9M Boehringer Milestone Payday
    BI is one of several drug developers with which Evotec has long-term discovery alliances; the others include Bayer, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca, ...
    7-8-2013
  • High-Tech Academic Centers Look to Milk Their Cash Cows
    ... weeks, Bayer HealthCare and Roche have agreed to work with QB3 startups, joining two other pharma giants that partner with the institute on that and other initiatives. Bayer ...
    7-1-2013
  • Onyx Spurns Amgen Offer, Pursues Its Own Deal
    Some 80% of that revenue came from two drugs co-marketed with Bayer HealthCare Pharmaceuticals: Nexavar (sorafenib) tablets for hepatocellular carcinoma (HCC), which is the most ...
    7-1-2013
  • Bayer, Seattle Genetics Launch Up to $520M ADC Collaboration
    to several oncology targets, to Bayer HealthCare, in a collaboration designed to produce new cancer treatments, the companies said today. Bayer agreed to pay up to $20 million in ...
    6-25-2013
  • 10 Industry-Venture Fund Alliances
    ... QB3 consists of UC's San Francisco (UCSF), Santa Cruz, and Berkeley campuses. Rights and/or options: Expected to be decided case-by-case. Announced: May 16 Bayer HealthCare + ...
    6-20-2013
  • Promising Phase III Results for Regeneron, Bayer mCNV Candidate
    Regeneron Pharmaceuticals and Bayer HealthCare today report positive top-line Phase III ... myopic choroidal neovascularization," Bayer HealthCare's Kemal Malik, M.D., head of ...
    6-6-2013
  • Maxygen Maxes Out
    a final $30 million from Bayer HealthCare in return for selling a recombinant factor VIIa product candidate (formerly MAXY-VII) and other hematology assets in 2008 for $90 million. ...
    6-4-2013
  • Merck, BMS Immunotherapy Data Whets Clinical Oncology Appetite...
    Meantime, BMS said its Yervoy® (ipilimumab) shrunk tumors in one-third of patients administered the treatment in a Phase I trial by at least 30%. Meantime, Bayer HealthCare ...
    6-3-2013
  • Bayer Prostate Cancer Drug Gains FDA Approval
    Bayer HealthCare said yesterday it is weeks away from joining Algeta in bringing to the ... Bayer HealthCare and Algeta will co-promote Xofigo in the U.S, with Bayer holding ...
    5-16-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Qiagen and Bayer HealthCare Agreement announced October 25, 2012 Collaboration where ... therapies developed by Bayer HealthCare, which are currently in early development." ...
    5-9-2013
  • Regeneron Gains Full Rights to Ophthalmology Antibodies from...
    The PDGF and ANG2 antibody families fit with one of Regeneron's areas of disease focus, eye disorders. In November 2011, the company joined Bayer HealthCare in launching the ...
    5-3-2013
  • The Globalization of IVD Companies
    share. In 2012, their share grew to 63%. The second tier group containing Alere, Bayer Diabetes Care Division, bioMerieux, Sysmex, and Becton, Dickinson and Co. also expanded ...
    5-1-2013
  • More »

    Journal Articles

  • Wound Repair Potential of Olea europaea L. Leaf Extracts Revealed...
    Ufuk Koca, Ipek Süntar, Esra Küpeli Akkol, Demet Yilmazer, Murat Alper
    Journal of Medicinal Food
    wound healing activity by using in vivo wound models of linear incision and circular excision in comparison with the reference ointment Madecassol® (Bayer, Istanbul, Turkey). ...
  • Performance of a New Blood Glucose Monitoring System in the Hands...
    Timothy S. Bailey, Jane F. Wallace, Joan Lee Parkes, Scott Pardo, Ji Yu, Holly C. Schachner, David A. Simmons, Amy Chu
    Diabetes Technology & Therapeutics
    Untrained subjects performed self-test fingersticks using a Microlet®2 lancing device (Bayer HealthCare LLC, Diabetes Care, Tarrytown, NY) followed by testing of their own ...
  • The Accuracy of Home Glucose Meters in Hypoglycemia
    Alper Sonmez, Zeynep Yilmaz, Gokhan Uckaya, Selim Kilic, Serkan Tapan, Abdullah Taslipinar, Aydogan Aydogdu, Mahmut Yazici, Mahmut Ilker Yilmaz, Muhittin Serdar, M. Kemal Erbil, Mustafa Kutlu
    Diabetes Technology & Therapeutics
    We evaluated the accuracy and the capillary and venous comparability of five different HGMs (Optium Xceed(tm) [Abbott Diabetes Care, Alameda, CA, USA], Contour® TS [Bayer Diabetes ...
  • Accuracy Evaluation of Five Blood Glucose Monitoring Systems...
    Cornelius Tack, Harald Pohlmeier, Thomas Behnke, Volkmar Schmid, Marco Grenningloh, Thomas Forst, Andreas Pfützner
    Diabetes Technology & Therapeutics
    [LifeScan Inc., Milpitas, CA], Accu-Chek® Aviva [Roche Diagnostics, Mannheim, Germany], and Contour® [Bayer Vital GmbH, Leverkusen, Germany]) in a daily routine setting. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll